Back to results
CompletedPhase 1Phase 2

N-Acetylcysteine for Neuroprotection in Parkinson's Disease

NCT01470027

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Weill Cornell Medical College

New York, New York, United States

View on ClinicalTrials.gov
N-Acetylcysteine for Neuroprotection in Parkinson's Disease — TrialFind